O’FALLON, Mo., March 31 /PRNewswire-FirstCall/ -- Synergetics USA, Inc. announced today that it released its newest electrosurgical product; the fourth generation of electrosurgical generators, named the Malis(R) Advantage(TM). The Company believes the worldwide market for electrosurgical generators exceeds $210 million annually. Synergetics currently only participates in the neurosurgical portion of this market through an OEM relationship. The Company believes the introduction of this product will allow it to directly participate in all of this larger market.
This product is the culmination of 40 years of development. In 1966, the Malis(R) generator was invented by brothers; the late Leonard I. Malis, M.D. and Jerry L. Malis, M.D. These products became the standard of care for intracranial neurosurgery and remain so today. Dr. Jerry Malis continues to serve as Synergetics’ Executive Vice President, Chief Scientific Officer and board member.
“Today represents a milestone for Synergetics and neurosurgery,” said Gregg D. Scheller, President and Chief Executive Officer of Synergetics. “We expect the Malis(R) Advantage(TM) to offer the neurosurgeon improvements in user interface, performance, safety, and convenience over the previous generation generator. It is a product that we are very excited about and should be a profit center for years to come. We have big goals for this product and hope to find many applications for it, both inside and outside of neurosurgery.”
Forward-Looking Statements
Some statements in this release may be “forward-looking statements” for the purposes of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “plan,” “potential,” “continue” or similar expressions. Such forward-looking statements are based upon current expectations and beliefs and are subject to a number of factors. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements, including but not limited to: the effects of local and national economic, credit and capital market conditions on the economy in general, and on the medical device industry in particular, and the effects of foreign exchange rates and interest rates; the ability to timely and cost-effectively integrate the operations and management of Valley Forge and Synergetics following their merger transaction; the ability to realize the synergies and other perceived advantages resulting from the merger; the ability to retain and attract key personnel; the ability of Synergetics to successfully execute its business strategy; the extent and timing of market acceptance of new products or product indications; the ability of Synergetics to procure, maintain, enforce and defend its patents and proprietary know how; changes in laws, including increased tax rates, regulations or accounting standards, third-party relations and approvals, and decisions of courts, regulators and governmental bodies; the ability of Synergetics to continue to increase customer loyalty; the ability to recoup costs of capital investments through higher revenues; environmental restrictions, soil and water conditions, weather and other hazards, site access matters and building permit issues; the effects of environmental and structural building conditions relating to Synergetics’ properties; acts of war or terrorism incidents; the effects of operating and market competition; and other important factors disclosed previously and from time to time in Synergetics’ filings with the SEC. Synergetics undertakes no obligation to update these forward-looking statements.
Contact: Synergetics USA, Inc. Pamela G. Boone Chief Financial Officer (636)-939-5100
Synergetics USA, Inc.
CONTACT: Pamela G. Boone, Chief Financial Officer of Synergetics USA,Inc., +1-636-939-5100
Web site: http://www.synergeticsusa.com/
